Nothing Special   »   [go: up one dir, main page]

Simon et al., 2010 - Google Patents

Improved in vivo detection of cortical lesions in multiple sclerosis using double inversion recovery MR imaging at 3 Tesla

Simon et al., 2010

View HTML
Document ID
16361321825900610316
Author
Simon B
Schmidt S
Lukas C
Gieseke J
Träber F
Knol D
Willinek W
Geurts J
Schild H
Barkhof F
Wattjes M
Publication year
Publication venue
European radiology

External Links

Snippet

Objective To investigate the impact of a higher magnetic field strength of 3 Tesla (T) on the detection rate of cortical lesions in multiple sclerosis (MS) patients, in particular using a dedicated double inversion recovery (DIR) pulse sequence. Methods Thirty-four patients …
Continue reading at link.springer.com (HTML) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
    • G01R33/00—Arrangements or instruments for measuring magnetic variables
    • G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
    • G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
    • G01R33/48—NMR imaging systems
    • G01R33/54—Signal processing systems, e.g. using pulse sequences, Generation or control of pulse sequences ; Operator Console
    • G01R33/56—Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution
    • G01R33/563—Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution of moving material, e.g. flow contrast angiography
    • G01R33/56341—Diffusion imaging
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
    • G01R33/00—Arrangements or instruments for measuring magnetic variables
    • G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
    • G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
    • G01R33/48—NMR imaging systems
    • G01R33/4806—Functional imaging of brain activation
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
    • G01R33/00—Arrangements or instruments for measuring magnetic variables
    • G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
    • G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
    • G01R33/48—NMR imaging systems
    • G01R33/4808—Multimodal MR, e.g. MR combined with positron emission tomography [PET], MR combined with ultrasound or MR combined with computed tomography [CT]
    • G01R33/481—MR combined with positron emission tomography [PET] or single photon emission computed tomography [SPECT]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
    • G01R33/00—Arrangements or instruments for measuring magnetic variables
    • G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
    • G01R33/28—Details of apparatus provided for in groups G01R33/44 - G01R33/64
    • G01R33/38—Systems for generation, homogenisation or stabilisation of the main or gradient magnetic field
    • G01R33/381—Systems for generation, homogenisation or stabilisation of the main or gradient magnetic field using electromagnets
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
    • G01R33/00—Arrangements or instruments for measuring magnetic variables
    • G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
    • G01R33/28—Details of apparatus provided for in groups G01R33/44 - G01R33/64
    • G01R33/38—Systems for generation, homogenisation or stabilisation of the main or gradient magnetic field
    • G01R33/3806—Open magnet assemblies for improved access to the sample, e.g. C-type or U-type magnets
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
    • G01R33/00—Arrangements or instruments for measuring magnetic variables
    • G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
    • G01R33/28—Details of apparatus provided for in groups G01R33/44 - G01R33/64
    • G01R33/42—Screening
    • G01R33/421—Screening of main or gradient magnetic field
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G01N2800/2821—Alzheimer

Similar Documents

Publication Publication Date Title
Simon et al. Improved in vivo detection of cortical lesions in multiple sclerosis using double inversion recovery MR imaging at 3 Tesla
Ciccarelli et al. Investigation of MS normal-appearing brain using diffusion tensor MRI with clinical correlations
Rovira et al. MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis—clinical implementation in the diagnostic process
Wattjes et al. Double inversion recovery brain imaging at 3T: diagnostic value in the detection of multiple sclerosis lesions
Phal et al. Qualitative comparison of 3-T and 1.5-T MRI in the evaluation of epilepsy
Brown et al. An abnormal periventricular magnetization transfer ratio gradient occurs early in multiple sclerosis
Blazejewska et al. Visualization of nigrosome 1 and its loss in PD: pathoanatomical correlation and in vivo 7 T MRI
Kim et al. High-b-value diffusion-weighted MR imaging of hyperacute ischemic stroke at 1.5 T
Kilsdonk et al. Improved differentiation between MS and vascular brain lesions using FLAIR* at 7 Tesla
Patankar et al. Dilatation of the Virchow-Robin space is a sensitive indicator of cerebral microvascular disease: study in elderly patients with dementia
Hasan et al. Diffusion tensor fractional anisotropy of the normal‐appearing seven segments of the corpus callosum in healthy adults and relapsing‐remitting multiple sclerosis patients
Mainero et al. In vivo imaging of cortical pathology in multiple sclerosis using ultra-high field MRI
Fotenos et al. Normative estimates of cross-sectional and longitudinal brain volume decline in aging and AD
Madai et al. Ultrahigh-field MRI in human ischemic stroke–a 7 tesla study
Kilsdonk et al. Multicontrast MR imaging at 7T in multiple sclerosis: highest lesion detection in cortical gray matter with 3D-FLAIR
Jansen et al. Cerebral blood flow, blood supply, and cognition in Type 2 Diabetes Mellitus
Kilsdonk et al. Morphological features of MS lesions on FLAIR* at 7 T and their relation to patient characteristics
Yoshiura et al. Arterial spin labelling at 3-T MR imaging for detection of individuals with Alzheimer’s disease
Roosendaal et al. In vivo MR imaging of hippocampal lesions in multiple sclerosis
Edjlali et al. Vessel wall MR imaging for the detection of intracranial inflammatory vasculopathies
Filippi et al. Microstructural magnetic resonance imaging of cortical lesions in multiple sclerosis
Delgado et al. Diagnostic performance of a new multicontrast one‐minute full brain exam (EPIMix) in neuroradiology: A prospective study
Wiggermann et al. FLAIR2: a combination of FLAIR and T2 for improved MS lesion detection
Krismer et al. Automated analysis of diffusion‐weighted magnetic resonance imaging for the differential diagnosis of multiple system atrophy from Parkinson's disease
Goncalves Filho et al. Accelerated post-contrast wave-CAIPI T1 SPACE achieves equivalent diagnostic performance compared with standard T1 SPACE for the detection of brain metastases in clinical 3T MRI